Autologous Tumor Infiltrating Lymphocytes Clinical Trials

3 actively recruiting trials

▲ +1 trial since August 2026

Also known as: GC101 TIL injection

Pipeline

Phase 1: 2Phase 2: 1

Top Sponsors

Shanghai Juncell Therapeutics2
Zhiyong Huang1

Indications

Cancer3
Lung Cancer2
Non Small Cell Lung Cancer2
Liver Disease1
Non-small Cell Lung Cancer Metastatic1

Other3 trials

A Phase II Study of GC101 in NSCLC

Phase 2

A Phase Ib Study of GC101 in NSCLC

Phase 1

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.